High-dose lung radiation shows promise in shrinking tumors
NCT ID NCT01803542
First seen Mar 21, 2026 · Last updated May 14, 2026 · Updated 4 times
Summary
This study is testing a type of radiation called stereotactic body radiation therapy (SBRT) for people with lung cancer or cancer that has spread to the lung. The treatment delivers high doses of radiation in just 3 to 10 sessions over 1 to 2 weeks. Researchers want to see how well it controls tumors and what side effects occur. About 200 adults with early-stage non-small cell lung cancer or limited lung metastases from other cancers will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Princess Margaret Hospital, University Health Network
RECRUITINGToronto, Ontario, M5G 2M9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.